I henhold til CHMPs guideline om risk management- systemer for humane lægemidler skal den opdaterede RMP indsendes samtidig med den næste sikkerhedsopdatering (PSUR).
As per the CHMP Guideline on Risk Management Systems for medicinal products for human use, the updated RMP should be submitted at the same time as the next Periodic Safety Update Report (PSUR).